海外の治験の状況「1」での検索結果
2657件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 地域
- 登録日
Not Recruiting
- Comparison of Bosutinib To Imatinib In Subjects With Newly Diagnosed Chronic Phase Philadelphia Chromosome Positive CML
- Chronic myelogenous leukemia (CML) MedDRA version: 17.0 Level: LLT Classification code 10009012 Term: Chronic myelogenous leukemia System Organ Class: 100000004864 ;Therapeutic area: Diseases [C] - Cancer [C04]
- Argentina, Belgium, Brazil, Canada, Chile, China, Colombia, France, Germany, Hong Kong, Hungary, India, Italy, Korea, Republic of, Latvia, Lithuania, Mexico, Netherlands, Peru, Poland, Romania, Russian Federation, Singapore, Slovenia, South Africa, Spain, Taiwan, Thailand, Turkey, Ukraine, United Kingdom
- 2008-01-07
Not recruiting
- Compare Bosutinib To Imatinib In Subjects With Newly Diagnosed Chronic Phase Philadelphia Chromosome Positive CML
- Chronic Myeloid Leukemia;Chronic Myeloid Leukemia;Chronic Myeloid Leukemia;Chronic Myeloid Leukemia
- Argentina, Belgium, Brazil, Canada, Chile, China, Colombia, Croatia, France, Germany, Hong Kong, Hungary, India, Italy, Japan, Korea, Republic of, Latvia, Lithuania, Mexico, Poland, Puerto Rico, Russian Federation, Singapore, Slovenia, South Africa, Spain, Taiwan, Thailand, Turkey, Ukraine, United Kingdom, United States
- 2007-12-13
Not recruiting
- A randomised trial of Enbrel (Etanercept) administered epidurally for the treatment of lumbosacral pain (sciatica)
- Sciatic pain
- Australia
- 2009-04-24
Not recruiting
- A Phase 2B Multicenter, Randomized, Comparative Trial Of UK-453,061 Versus Etravirine In Combination With Darunavir/Ritonavir And A Nucleos(t)Ide Reverse Transcriptase Inhibitor For The Treatment Of Antiretroviral Experienced HIV-1 Infected Subjects With Evidence Of NNRTI Resistant HIV-1
- HIV-1;HIV-1;HIV-1;HIV-1
- Argentina, Brazil, Canada, France, Germany, Italy, Malaysia, Poland, Portugal, Puerto Rico, South Africa, Spain, Taiwan, Ukraine, United Kingdom, United States
- 2009-01-15
Recruiting
- A Phase 1/2 Study of Valproate in Combination with Interferon alpha in Relapsed, Recurrent or Progressive Neuroblastoma
- Relapsed, Recurrent or Progressive Neuroblastoma
- Australia, New Zealand
- 2010-10-06
Not Recruiting
- Clinical research study involving an experimental drug named cobicistat (GS-9350, COBI) which is being studied in combination with drugs already approved for the treatment of HIV-1 infection. The purpose of this study is to see if COBI when given in combination with atazanavir and FTC/TDF is safe and effective in reducing levels of HIV-1 in the blood of subjects who are treatment-naïve (those who have not received any antiretroviral medication)
- Human Immunodeficiency Virus (HIV-1) Infections MedDRA version: 14.1 Level: LLT Classification code 10020192 Term: HIV-1 System Organ Class: 10021881 - Infections and infestations ;Therapeutic area: Diseases [C] - Virus Diseases [C02]
- Australia, Austria, Belgium, Brazil, Canada, Denmark, Dominican Republic, France, Germany, Italy, Netherlands, Portugal, Spain, Sweden, Switzerland, Thailand, United Kingdom, United States
- 2010-04-01
Not recruiting
- A randomised phase II study evaluating Dual inhibition of epidermal growth factor receptor (EGFR) signalling using CetUXimab and Erlotinib or dose escalated Cetuximab in patients with chemotherapy refractory KRAS wild-type metastatic colorectal cancer
- Metastatic colorectal cancer;EGFR inhibitor induced skin toxicity
- Australia, New Zealand
- 2011-11-01
Not recruiting
- A Phase IIA Trial to Evaluate the Safety and Immunogenicity of a DNA HIV-1 Vaccine Followed by an MVA HIV-1 Vaccine in HIV-uninfected Volunteers
- HIV Infections
- Kenya, United Kingdom
- 2011-05-31
Recruiting
- The role of Vitamin C in managing type 2 diabetes: Vitamin C, Thiazolidinediones and their combined effect on Adiponectin
- Type 2 diabetes
- Australia
- 2011-05-10
Recruiting
- CF-IDEA (Cystic Fibrosis - Insulin Deficiency, Early Action): Randomised controlled trial of once-daily insulin detemir in patients with cystic fibrosis and early insulin deficiency
- Cystic Fibrosis;Insulin Deficiency; Cystic Fibrosis Insulin Deficiency;Respiratory - Other respiratory disorders / diseases
- Australia
- 2011-01-19
Not recruiting
- A Study of Herceptin (Trastuzumab) in Women With Human Epidermal Growth Factor Receptor (HER) 2-Positive Advanced and/or Metastatic Breast Cancer
- Breast Cancer;Breast Cancer;Breast Cancer;Breast Cancer
- Australia, Brazil, Canada, Costa Rica, Finland, France, Greece, Guatemala, Italy, Mexico, Panama, Poland, Spain, Sweden, United Kingdom
- 2016-04-20
Recruiting
- An evaluation of the performance and user acceptance of a mobile real-time continuous glucose monitoring system in people with type 1 and type 2 diabetes treated with multiple daily injections of insulin.
- Diabetes Mellitus
- Australia
- 2016-03-31
Recruiting
- Long-Term, Open-Label Study With a Double-Blind, Placebo-Controlled, Randomized Drug Withdrawal Period of LUM001, an Apical Sodium-Dependent Bile Acid Transporter Inhibitor (ASBTi), in Patients With Alagille Syndrome
- Alagille Syndrome;Q44.7 - Other congenital malformations of liver
- Australia, Belgium, Canada, France, Germany, Poland, Spain, United Kingdom
- 2016-03-22
Not recruiting
- A Dose Frequency Optimization,Trial of Nivolumab 240 mg Every 2 Weeks vs Nivolumab 480 mg Every 4 Weeks in Subjects With Advanced or Metastatic Non-small Cell Lung Cancer Who Received Up to 12 Months of Nivolumab at 3 mg/kg or 240 mg Every 2 Weeks
- Lung Cancer
- Australia, Austria, Canada, France, Germany, Ireland, Italy, Spain, United States
- 2016-03-11
Not recruiting
- Evaluating the Pharmacokinetics, Tolerability, and Safety of Once-Weekly Rifapentine and Isoniazid in HIV-1-Infected and HIV-1-Uninfected Pregnant and Postpartum Women With Latent Tuberculosis Infection
- Tuberculosis
- Haiti, Kenya, Malawi, Thailand, United States, Zimbabwe
- 2016-01-07
Recruiting
- A Dose Frequency Optimization, Phase IIIB/IV Trial of Nivolumab 240 mg Every 2 Weeks vs Nivolumab 480 mg Every 4 Weeks in Subjects With Advanced or Metastatic Non-small Cell Lung Cancer Who Received up to 12 Months of Nivolumab at 3 mg/kg or 240 mg Every 2 Weeks
- Lung Cancer;C34 - Malignant neoplasm of bronchus and lung
- Australia, Austria, Canada, France, Germany, Italy, Spain, United States
- 2017-02-02
Not recruiting
- A follow-on Safety Study in Subjects With Crohn's Disease Who Have Previously Been Withdrawn From the Double-blind Study CDP870-031 [NCT00152490] or CDP870-032 [NCT00152425] Due to an Exacerbation of Crohn's Disease
- Crohn's Disease;Crohn's Disease;Crohn's Disease;Crohn's Disease
- Australia, Austria, Belarus, Belgium, Bulgaria, Canada, Czech Republic, Denmark, Estonia, Germany, Hungary, Israel, Italy, New Zealand, Norway, Poland, Russian Federation, Serbia, Singapore, Slovenia, South Africa, Spain, Ukraine, United States
- 2005-09-08
Not recruiting
- Study Comparing Etanercept Plus Methotrexate to Either Etanercept or Methotrexate Alone in Rheumatoid Arthritis.
- Active Rheumatoid Arthritis
- Australia, Austria, Belgium, Czech Republic, Denmark, Finland, France, Germany, Greece, Israel, Italy, Netherlands, Norway, Poland, Portugal, Romania, Spain, Sweden, United Kingdom
- 2006-10-26
Not recruiting
- Safety and Efficacy of Imatinib Versus Interferon-a Plus Cytarabine in Patients With Newly Diagnosed Philadelphia Chromosome Positive Chronic Myelogenous Leukemia
- Chronic Myelogenous Leukemia;Chronic Myelogenous Leukemia;Chronic Myelogenous Leukemia;Chronic Myelogenous Leukemia
- Australia, Austria, Belgium, Canada, Denmark, France, Germany, Italy, Netherlands, New Zealand, Norway, Spain, Sweden, Switzerland, United Kingdom, United States
- 2006-06-02
Not recruiting
- Herceptin (Trastuzumab) in Treating Women With Human Epidermal Growth Factor Receptor (HER) 2-Positive Primary Breast Cancer
- Breast Cancer;Breast Cancer;Breast Cancer;Breast Cancer
- Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Croatia, Denmark, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Ireland, Israel, Italy, Japan, Korea, Republic of, Netherlands, Poland, Portugal, Russian Federation, Singapore, South Africa, Spain, Sweden, Switzerland, Thailand, United Kingdom
- 2002-09-06
